openPR Logo
Press release

Global Biosimulation Market to Reach a Value of About US$ 1,750 Mn in the Year 2022

Global Biosimulation Market to Reach a Value of About US$ 1,750 Mn

In the process of biosimulation, the computer aided mathematical models are used to simulate the biological processes. Biosimulation is an important part of systems biology and helps in the discovery and development of new drugs, in the area of drug metabolism and in the modeling of biomedical systems that are complex. There is a growing demand for reduction in the cost of discovery of new drugs and the risk of failure at a later stage in the development of new drugs is too high. In order to counter such problems, biosimulation is used as a predictive tool and it helps in the prediction of the future outcomes of the drug development by simulation of the biological processes involved. This is the main factor supporting the growth of the global biosimulation market. However, high costs associated with the R&D related to biosimulation and a lack of qualified workforce are the main restraints hampering the growth of this market.

The global biosimulation market is slated to touch a value of about US$ 1,750 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/3726

4 Forecast Highlights on Global Biosimulation Market

As per the forecast of Persistence Market Research, the services product type segment is slated to touch a value of nearly US$ 700 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The services product type segment is estimated to account for more than one-third of the revenue share of the product segment by the year 2017 and is forecasted to gain market share by 2022 over 2017.
As per the forecast of Persistence Market Research, the pharmaceutical and biotech companies segment will reach a value of about US$ 350 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The pharmaceutical and biotech companies segment is forecasted to account for more than one-third of the total revenue share of the end user segment by the end of the year 2017 and is expected to lose in market share by 2022 as compared with the year 2017.
As per the forecast of Persistence Market Research, the drug development segment is slated to reach a value of nearly US$ 1,000 Mn in 2022. The drug development segment is expected to gain market share by the end of the year 2022. The largest share is contributed by the North America region in the drug development segment.
Persistence Market Research forecasts the U.S. biosimulation market to exhibit a compound annual growth rate (CAGR) of more than 13% from 2017 to 2022.

Request TOC@ https://www.persistencemarketresearch.com/methodology/3726

The report has also included the profiles of some of the leading companies in the biosimulation market like Dassault Systemes SE, Acceryls Inc., Schrodinger, Inc., Leadscope Inc., Certara, L.P., Entelos, Inc., Advanced Chemistry Development, Inc., Evidera, Inc., Simulations Plus, Inc. and Genedata AG.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biosimulation Market to Reach a Value of About US$ 1,750 Mn in the Year 2022 here

News-ID: 1195420 • Views:

More Releases from Persistence Market Research

Frozen Pastries Market to Reach $3.8 Bn by 2032 Driven by Convenience and Ready-to-Eat Demand
Frozen Pastries Market to Reach $3.8 Bn by 2032 Driven by Convenience and Ready- …
The global frozen pastries market is set for consistent expansion over the next decade, driven by the growing demand for convenient, ready-to-bake bakery products and evolving consumer lifestyles. According to market projections, the global frozen pastries market size is likely to be valued at US$ 2.6 billion in 2025 and is estimated to reach US$ 3.8 billion by 2032, growing at a CAGR of 5.7% during the forecast period from
Cookies Market to Reach US$ 54.4 Bn by 2032 Driven by Rising Demand for Premium Snacks
Cookies Market to Reach US$ 54.4 Bn by 2032 Driven by Rising Demand for Premium …
The global cookies market is witnessing steady growth, with its valuation expected to reach US$ 38.3 billion in 2025. According to projections, the market is set to rise significantly and reach approximately US$ 54.4 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.1% between 2025 and 2032. This growth trajectory is fueled by evolving consumer lifestyles, increasing demand for convenient and on-the-go snacks, and the rising
Flaxseeds Market Growth Driven by Health Trends | Valued at US$ 1,284.7 Mn in 2025
Flaxseeds Market Growth Driven by Health Trends | Valued at US$ 1,284.7 Mn in 20 …
The global flaxseeds market is witnessing substantial expansion, driven by the growing consumer awareness of health benefits associated with flaxseed consumption and its increasing use across diverse industries such as food and beverages, pharmaceuticals, and cosmetics. According to recent industry analysis, the global flaxseeds market size is likely to be valued at US$ 1,284.7 million in 2025, and is projected to reach US$ 2,145.3 million by 2032, expanding at a
Sterols Market Growth: Valued at $1,268.6 Mn in 2025 to Reach $2,261.7 Mn by 2032 Driven by Rising Health Awareness
Sterols Market Growth: Valued at $1,268.6 Mn in 2025 to Reach $2,261.7 Mn by 203 …
The global sterols market is on a trajectory of robust expansion, anticipated to reach a valuation of US$1,268.6 million in 2025 and further grow to US$2,261.7 million by 2032, registering a healthy CAGR of 8.6% during the forecast period (2025-2032). Sterols, a group of naturally occurring compounds found in plants and animals, are gaining increasing attention across multiple industries due to their functional and health-promoting benefits. The growing global demand

All 5 Releases


More Releases for Biosimulation

Key Trends Influencing the Growth of the Biosimulation Market in 2025: Innovatio …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Is the Expected CAGR for the Biosimulation Market Through 2025? The size of the biosimulation market has seen a significant increase lately. This market is projected to expand from a total value of $4.47 billion in 2024 to $5.02 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. The historic
Global Healthcare Expenditure Boosts Biosimulation Market Growth: A Significant …
The Biosimulation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Biosimulation Market Size and Projected Growth Rate? The size of the biosimulation market has expanded significantly in the past few years. Starting from a valuation of $4.47 billion in 2024, it's forecasted to
Primary Catalyst Driving Biosimulation Market Evolution in 2025: Global Healthca …
What market dynamics are playing a key role in accelerating the growth of the biosimulation market? The anticipated rise in global healthcare expenditure is predicted to bolster the biosimulation market throughout the forecast period. The uptick in healthcare expenses is expected to increase spending on drug development, consequently fueling revenue from biosimulation solutions. Currently, biosimulation software is utilized in drug development to imitate diseases. This software enables the conduct of virtual
North America Biosimulation Market
The global biosimulation market is experiencing rapid expansion, driven by advancements in technology and the increasing demand for computational tools that can accelerate drug discovery, clinical trials, and regulatory processes. As of 2023, the market was valued at USD 3.5 billion and is projected to reach USD 14.1 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 16.90% from 2024 to 2032. Biosimulation, which involves the use of
Global Biosimulation Market Research Report 2023-2029
Biosimulation report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosimulation market is projected to reach US$ 3686.5 million in 2029, increasing from US$ 1580.2 million in 2022, with the CAGR of 12.7% during the period of 2023 to 2029. Demand from Hospital and Scientific Research Institutions are the major drivers for the industry. Global Biosimulation Market: Driven factors and Restrictions factors The research
Biosimulation Technology Market - Precision Modeling, Transformative Insights: B …
Newark, New Castle, USA: The "Biosimulation Technology Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Biosimulation Technology Market: https://www.growthplusreports.com/report/biosimulation-technology-market/7766 This latest report researches the industry structure, sales, revenue,